MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.

    I. Aracil-Bolaños, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, S. Martínez-Horta, JM. González-de-Echávarri, J. Pérez-Pérez, H. Bejr-Kasem, B. Pascual-Sedano, MA. Boti, A. Campolongo, C. Izquierdo, A. Gironell, B. Gómez-Ansón, J. Pagonabarraga, J. Kulisevksy (Barcelona, Spain)

    Objective: To profile the neural correlates of neuropsychological assessment according to the Movement Disorders Society Task Force Criteria in its Level-1 and Level-2 recommendations Background:…
  • 2019 International Congress

    Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

    A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

    Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…
  • 2019 International Congress

    Patterns of neuropsychological profiles according to severity of depressive symptoms in newly diagnosed Parkinson’s disease patients

    SJ. Kim (Busan, Republic of Korea)

    Objective: In our study, we analyzed clinical neuropsychological profiles according to severity of depressive symptoms in newly diagnosed Parkinson’s disease patients. Background: Depression is common…
  • 2019 International Congress

    Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies

    E. Matar, K. Ehgoetz Martens, J. Phillips, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…
  • 2019 International Congress

    Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients

    O. Monchi, JR. Sarna, D. Martino, Z. Gan-Or, JA. Ruskey, T. Alrazi, A. Robichaud, T. Hammer, ST. Lang, J. Cheetham, E. Yoon, M. Kibreab, I. Kathol, JS. Provost, M. Ramezani (Calgary, AB, Canada)

    Objective: To assess the effect of rs894280 of Sybnuclein-alpha (SNCA)gene on cognitive profile of idiopathic Parkinson’s disease (PD) patients and patterns of neuronal activity during a set-shifting…
  • 2019 International Congress

    Mild Cognitive Impairment in Young Onset Parkinson Disease

    A. Troster, C. Schweer (Phoenix, AZ, USA)

    Objective: To identify the prevalence of Parkinson disease mild cognitive impairment (PD-MCI) in a group of persons with young onset Parkinson disease (YOPD) consecutively referred…
  • 2019 International Congress

    Tissue Engineered Nigrostriatal Pathway as an Anatomically-Inspired Test-Bed for Evaluating Axonal Pathophysiology

    E. Clark, L. Struzyna, W. Gordian-Velez, I. Chen, J. Duda, D.K. Cullen (Philadelphia, PA, USA)

    Objective: We previously developed the first micro-tissue engineered nigrostriatal pathway encased in a tubular hydrogel with 3D structure, multicellular composition, and architecture of long axonal…
  • 2019 International Congress

    Dopamine substitution increases connectivity between premotor and motor areas in Parkinson’s disease – a DCM-Study

    P. Loehrer, V. Seeger, I. Weber, C. Oehrn, H. Dafsari, M. Tittgemeyer, L. Timmermann (Marburg, Germany)

    Objective: To assess the influence of dopaminergic depletion in Parkinson’s disease (PD) on connectivity parameters within the cortical motor network. Background: Integration of neuronal information…
  • 2019 International Congress

    Functional Proteomic Analysis of Leukocytes from Parkinson’s Disease Patients: A Clinical Perspective on Biomarkers Identification

    N. Woldmar, B. Fadel, G. Poralla, L. Giacomin, J. Evaristo, F. Nogueira, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

    Objective: The aim of this work was to identify proteomic profiles associated with specific Parkinson’s disease (PD) clinical groups in leukocytes of patients from Rio…
  • 2019 International Congress

    Frequency of Cardiovascular Abnormalities in Mexican Patients with Early Parkinson´s Disease

    JA. Juárez, M. Violante, A. Arriaga, A. González, A. Salas, L. Vidal, R. Vicioso, C. Roa, I. López, M. Soto (Mexico, Mexico)

    Objective: To determine frequency of cardiovascular abnormalities and autonomic dysfunction in the early course of Parkinson's disease Background: Parkinson´s disease (PD) is a neurodegenerative disease…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley